IP Cases — 2024
6,517 decisions across all jurisdictions
Page 212 of 218 · 6,517 total
TESLA, INC. v.iQar Inc.
Tesla successfully secured the institution of Inter Partes Review against iQar Inc.'s patent 10,829,002, challenging claims related to vehicle destination prediction and power management.
Visa, Inc. v.Cortex MCP, Inc.
Visa, Inc.'s IPR petition against Cortex MCP, Inc.'s patent was instituted by the PTAB, allowing the case to proceed to trial. The Board adopted key claim constructions, including defining 'OVER file' to encompass tokens and NFC interactions for 'scan,' confirming sufficient basis for unpatentability arguments.
Visa, Inc. v.Cortex MCP, Inc.
Visa, Inc., successfully petitioned for institution in a high-stakes IPR against Cortex MCP, Inc.'s digital credentialing patent (9251531). The Board adopted key claim constructions favorable to the Petitioner and found sufficient evidence of obviousness based on prior art references.
Visa, Inc. v.Cortex MCP, Inc.
Visa's claims against Cortex MCP were upheld by the PTAB Director in a review of the Final Written Decision. The Board confirmed that Oborne discloses the token verification limitation central to Visa's patent.
TESLA, INC. v.iQar Inc.
The Board found all challenged claims unpatentable over combinations of Kudo-325 and Kudo-066. The petitioner successfully argued that the prior art combination teaches or suggests the necessary elements for destination prediction and power management in vehicles. This final decision affirms the obviousness rejection against iQar Inc.'s patent.
Visa, Inc. v.Cortex MCP, Inc.
The Board found that the majority of claims (24 out of 33) were unpatentable over various combinations of prior art references. The key finding was that Oborne teaches core tokenization elements, while other combinations failed to provide sufficient motivation for the claimed improvements.
R Indira Devi v.G Satyaki
The appeal challenged a trial court judgment regarding copyright infringement and passing off concerning literary works. The plaintiff claimed ownership based on an assignment letter from his father, while the defendant contested the claims. The High Court upheld the trial court's finding that the suit was not barred by limitation.
Novartis Ag v.Natco Pharma Limited
The court passed an order addressing two interlocutory applications filed by the defendant. The first application led to the addition of a specific issue concerning the validity of Patent IN 233161 under Section 3(d) of the Patents Act, 1970. The second application modified the schedule for leading evidence.
E R Squibb And Sons Llc v.Beacon Pharmaceuticals Limited
The Plaintiffs filed a suit alleging that the Defendants were infringing their Indian Patent No. 340060, which covers the drug Nivolumab. The court examined the patent's validity and prima facie case before issuing interim directions.
M/S Mrs. Bectors Food Specialities Ltd. v.M/S National Biscuits And Sweet Mfrs.
The Delhi High Court allowed the plaintiff, M/S Mrs. Bectors Food Specialities Ltd., to implead two additional parties—M/s Satnam Mart Private Limited and M/s JK Print Pack—in its ongoing trademark infringement suit against M/S National Biscuits And Sweet Mfrs. This move was based on evidence gathered during a local commission inspection, which revealed that the defendant's infringing products were manufactured by Satnam Mart and printed by JK Print Pack. The court proceeded to issue summonses to these newly added defendants, ensuring the litigation can proceed against all responsible parties.
havells india limited v.azad singh
Havells India Limited sued Azad Singh for trademark infringement and passing off, alleging that Azad Singh's use of 'REO-LT' on low tension wires deceptively imitated Havells’ registered trademark 'REO'. Havells claimed significant brand recognition and consumer confusion due to the similarity between the marks.
Uzdaroji Akcine Bendrove (Uab) Baltijos Mineraliniu Vandenu Kompanija v.Mr. Sahil Tandon Trading As A And Z Exports International & Anr.
The Delhi High Court allowed the petition filed by Uzdaroji Akcine Bendrove (UAB) against Mr. Sahil Tandon, leading to the cancellation of a registered trademark for 'TICHE' in Class 32. The court found that UAB was the prior and legitimate adopter of the mark since 1998, citing extensive international use and evidence of trans-border reputation spilling over into India. The judgment underscores the importance of proving prior usage and bona fide adoption when challenging a trademark registration.
Ortovox Sportartikel GmbH v.Mammut Sports Group AG, Mammut Sports Group GmbH
Unified Patent Court decision.
Sanofi-Aventis Deutschland GmbH v.Amgen, Inc.
Unified Patent Court decision.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
Unified Patent Court decision.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy’s labs and Eye Therapies have jointly filed a motion to keep their settlement agreement confidential and separate from the IPR docket. The request cites statutory authority and seeks limited disclosure.
Motorola Solutions, Inc. v.STA Group, LLC
Motorola Solutions and STA Group settled their dispute over Patent 8,145,249, filing a joint motion that led the PTAB to terminate the inter partes review.
Motorola Solutions, Inc. v.STA Group, LLC
Motorola Solutions and STA Group filed a joint motion asking the PTAB to keep their settlement agreement confidential under 35 U.S.C. § 317(b). They contend the agreement contains highly sensitive business information that could be harmed if disclosed.
Motorola Solutions, Inc. v.STA Group, LLC
Motorola Solutions and STA Group have settled their dispute over a VoIP audio‑mixing patent and jointly moved to terminate the pending inter partes review.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy’s Laboratories and Eye Therapies have settled their dispute over U.S. Patent No. 11,833,245 and jointly filed a motion to terminate the inter partes review. The Board is asked to end the proceeding under 35 U.S.C. § 317, citing policy and precedent favoring termination after settlement.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy’s Laboratories and Eye Therapies entered a settlement that led to the joint termination of two inter partes review proceedings covering patents 11,833,245 and 11,596,600. The Board granted the termination and kept the settlement agreement confidential.
LUMI LEGEND CORPORATION v.Manehu Product Alliance, LLC
Lumi Legend has filed a PGR petition seeking cancellation of claims 33‑36 of U.S. Patent 11,781,703, alleging lack of written description, indefiniteness, anticipation, and obviousness. The petition relies on prior art such as Clary, Juan, Pankros, Tsuji, and Xu. It also argues the patent is eligible for PGR and urges the Board not to deny institution.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy's Laboratories challenges Eye Therapies' patent (11833245) in an IPR, arguing all claims are obvious over prior art including Gil and Norden. The petition asserts that the combination of known elements for treating eye redness is motivated by POSA knowledge, favoring institution under Hatch-Waxman principles.
Motorola Solutions, Inc. v.STA Group, LLC
Motorola Solutions challenges STA Group's 8145249 patent, arguing that its core technology for mixing disparate communication streams is obvious over prior art. The petition asserts multiple grounds of obviousness (35 U.S.C. § 103) using references like Botha and combinations involving Radenkovic and McDonald.
LUMI LEGEND CORPORATION v.Manehu Product Alliance, LLC
LUMI LEGEND CORPORATION successfully petitioned for institution of its PGR against Manehu Product Alliance regarding television mounting systems. The Board found that the petitioner met the likelihood standard by asserting claims 33-36 are likely unpatentable over a combination of Clary and Tsuji, despite patent owner arguments about mechanical interference.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy's Laboratories successfully secured institution status for an IPR against Eye Therapies, LLC regarding ophthalmic formulations. The Board found a reasonable likelihood of prevailing on obviousness (35 U.S.C. § 103) based on the combination of prior art references.
Motorola Solutions, Inc. v.STA Group, LLC
Motorola Solutions successfully petitioned the PTAB, leading to trial on all challenged claims of STA Group's patent (8145249). The Board found that Petitioner demonstrated a reasonable likelihood of prevailing in its obviousness challenge under 35 U.S.C. § 103(a) against multiple prior art references. This decision moves the dispute toward full trial, significantly advancing Motorola's position.
Vidli Restaurants Limited v.Alok Sovind Chandewar
Vidli Restaurants Limited filed a Commercial Arbitration Application seeking dispute resolution related to its Franchise Agreement with Alok Sovind Chandewar. The core of the dispute involved Vidli alleging that the Respondent was using a deceptively similar mark, constituting trademark infringement post-termination of the agreement. However, the Bombay High Court dismissed the application, ruling that since Vidli was merely a licensee and not the owner of the trademarks, it lacked the legal standing to initiate arbitration over the alleged infringement.
F.Hoffmann-La Roche Ag v.Assistant Controller of Patents and Designs, Government of India
F.Hoffmann-La Roche Ag appealed an order rejecting its patent application for a subcutaneous anti-HER2 antibody formulation. The rejection was based on the product lacking inventive step and being known in the market. The court allowed the appeal, noting that the original decision failed to address 11 out of 12 claims independently.
Fibrocell Technologies Inc. v.Controller Of Patents
Fibrocell Technologies Inc. appealed an impugned order dated February 19, 2019, passed by the Controller of Patents which denied its application (No. 10246/DELNP/2012). The appellant argued that the denial was based on new grounds (lack of enablement) and non-speaking reasons, violating natural justice.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.